Skip to content

Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 (ST6GALNAC2)

Homo sapiens — UniProt Q9UJ37

Gene: ST6GALNAC2Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 (ST6GALNAC2) is a protein from Homo sapiens identified by UniProt accession Q9UJ37, 374 residues long. MolForge cross-references it against 0 known binders and 100 disease associations.

  • UniProt accession: Q9UJ37; gene symbol ST6GALNAC2.
  • Organism: Homo sapiens.
  • Length: 374 amino acids.
  • Top disease associations (Open Targets): COVID-19, severe acute respiratory syndrome and neurodegenerative disease.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameAlpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2
UniProt accessionQ9UJ37
GeneST6GALNAC2
OrganismHomo sapiens
Length374 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (100)

Diseases linked to this target (Open Targets).

  • COVID-19 · score 0.46
  • severe acute respiratory syndrome · score 0.37
  • neurodegenerative disease · score 0.26
  • head and neck squamous cell carcinoma · score 0.12
  • endometrial cancer · score 0.10
  • breast adenocarcinoma · score 0.10
  • gastric adenocarcinoma · score 0.10
  • total cholesterol measurement · score 0.09
  • neutrophil count · score 0.06
  • isolated agammaglobulinemia · score 0.05

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9UJ37-F1alphafoldPREDICTED85.47—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q9UJ37.

Amino-acid sequence (374 residues)

MGLPRGSFFW LLLLLTAACS GLLFALYFSA VQRYPGPAAG ARDTTSFEAF FQSKASNSWT GKGQACRHLL HLAIQRHPHF RGLFNLSIPV LLWGDLFTPA LWDRLSQHKA PYGWRGLSHQ VIASTLSLLN GSESAKLFAP PRDTPPKCIR CAVVGNGGIL NGSRQGPNID AHDYVFRLNG AVIKGFERDV GTKTSFYGFT VNTMKNSLVS YWNLGFTSVP QGQDLQYIFI PSDIRDYVML RSAILGVPVP EGLDKGDRPH AYFGPEASAS KFKLLHPDFI SYLTERFLKS KLINTHFGDL YMPSTGALML LTALHTCDQV SAYGFITSNY WKFSDHYFER KMKPLIFYAN HDLSLEAALW RDLHKAGILQ LYQR

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with ST6GALNAC2?

The strongest Open Targets associations for ST6GALNAC2 are COVID-19, severe acute respiratory syndrome, neurodegenerative disease, head and neck squamous cell carcinoma and endometrial cancer.

How long is the ST6GALNAC2 protein?

The Homo sapiens ST6GALNAC2 protein (UniProt Q9UJ37) is 374 amino acids long.

Browse: Targets: S · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9UJ37
GeneST6GALNAC2
OrganismHomo sapiens
Length374
Binders0
Diseases100
View on UniProt